Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines

Journal of Infectious Diseases

Volumn 177, Issue 2, 1998, Pages 310-319

  Graham, Barney S ^a   McElrath, M Juliana ^c   Connor, Ruth I ^c   Schwartz, David H ^c   Gorse, Geoffrey J ^c   Keefer, Michael C ^c   Mulligan, Mark J ^c   Matthews, Thomas J ^c   Wolinsky, Steven M ^c   Montefiori, David C ^c   Vermund, Sten H ^c   Lambert, John S ^b   Corey, Lawrence ^c   Belshe, Robert B ^c   Dolin, Raphael ^c   Wright, Peter F ^c   Korber, Bette T ^c   Wolff, Mark C ^c   Fast, Patricia E ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VIRUS LOAD;

EID: 17344371942     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514209     Document Type: Article

References (16)

1. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: World Health Organization, 1988.
2. Wright PF, Kim-Farley RJ, de Quadros CA, et al. Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 1991;325:1774-9.
3. Graham BS, Wright PF. Candidate AIDS vaccines. N Engl J Med 1995;333:1331-9.
4. Nui MT, Stein DS, Schnittman SM. Primary HIV-1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 1993;168:1490-501.
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-10.
6. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994;370:463-7.
7. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-5.
8. Graziosi C, Pantaleo G, Butini L, et al. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993;90:6405-9.
9. Kinloch-de Loes S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis 1993;17:59-65.
10. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
11. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321:1626-31.
12. Khadir A, Coutlee F, Saint-Antoine P, Olivier C, Voyer H, Kessous-Elbaz A. Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells. J Acquir Immune Deficiency Syndr 1995;9:257-63.
13. Graham BS, Matthews TJ, Belshe RB, et al. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. J Infect Dis 1993;167:533-7.
14. Dolin R, Graham BS, Greenberg SB, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. Ann Intern Med 1991;114:119-27.
15. Wolinsky SM, Wike C, Korber BTM, et al. Selective transmission of human immunodeficiency virus type 1 variants from mothers to infants. Science 1992;255:1134-7.
16. Koot M, Vos AHV, Keet RPM, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.